irsogladine has been researched along with misoprostol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bensadoun, RJ; Keefe, D; Lalla, RV; Schubert, MM | 1 |
| Amagase, K; Satoh, H; Takeuchi, K | 1 |
1 review(s) available for irsogladine and misoprostol
| Article | Year |
|---|---|
Anti-inflammatory agents in the management of alimentary mucositis.
Topics: Allopurinol; Animals; Anti-Inflammatory Agents; Anti-Ulcer Agents; Antineoplastic Agents; Benzydamine; Clinical Trials as Topic; Drug Evaluation; Evidence-Based Medicine; Flurbiprofen; Gastrointestinal Diseases; Health Services Needs and Demand; Humans; Metalloproteins; Misoprostol; Mucositis; Neoplasms; Practice Guidelines as Topic; Radiation-Protective Agents; Radiotherapy; Research Design; Severity of Illness Index; Stomatitis; Triazines | 2006 |
1 other study(ies) available for irsogladine and misoprostol
| Article | Year |
|---|---|
Mucosal protective agents prevent exacerbation of NSAID-induced small intestinal lesions caused by antisecretory drugs in rats.
Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Diclofenac; Dose-Response Relationship, Drug; Gastric Mucins; Gastrointestinal Agents; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; Male; Misoprostol; Mucus; Omeprazole; Protective Agents; Proton Pump Inhibitors; Quinolones; Ranitidine; Rats; Rats, Wistar; Sus scrofa; Triazines | 2014 |